346 Efficacy and safety of mifepristone and sublingual misoprostol for second trimester medical abortion. A prospective study

Abstract

Background: Second trimester pregnancy termination is part of comprehensive women’s care. This study aimed to evaluate the efficacy and safety of mifepristone combined with sublingual misoprostol for the second trimester medical abortion. Materials and Methods: This is an ongoing prospective observational study in a tertiary unit and we report the preliminary results from July 2020 to April 2021. The study included singleton pregnancies that underwent second trimester (15+0 to 27+6 weeks) medical abortion due to fetal congenital anomalies or demise.